Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.

Christlieb SB, Strandholdt CN, Olsen BB, Mylam KJ, Larsen TS, Nielsen AL, Rohde M, Gerke O, Olsen KE, Møller MB, Kristensen BW, Abildgaard N, Alavi A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1824-36. doi: 10.1007/s00259-016-3385-6.

PMID:
27102266
2.

In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.

Dam JH, Olsen BB, Baun C, Høilund-Carlsen PF, Thisgaard H.

Mol Imaging Biol. 2016 Jun;18(3):368-76. doi: 10.1007/s11307-015-0911-z.

PMID:
26561028
3.

The Basic Principles of FDG-PET/CT Imaging.

Basu S, Hess S, Nielsen Braad PE, Olsen BB, Inglev S, Høilund-Carlsen PF.

PET Clin. 2014 Oct;9(4):355-70, v. doi: 10.1016/j.cpet.2014.07.006. Review.

PMID:
26050942
4.

Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy.

Thisgaard H, Olsen BB, Dam JH, Bollen P, Mollenhauer J, Høilund-Carlsen PF.

J Nucl Med. 2014 Aug;55(8):1311-6. doi: 10.2967/jnumed.114.137182.

5.

Cognitive remediation combined with an early intervention service in first episode psychosis.

Østergaard Christensen T, Vesterager L, Krarup G, Olsen BB, Melau M, Gluud C, Nordentoft M.

Acta Psychiatr Scand. 2014 Oct;130(4):300-10. doi: 10.1111/acps.12287.

PMID:
24833315
6.

The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.

Schnitzler A, Olsen BB, Issinger OG, Niefind K.

J Mol Biol. 2014 May 1;426(9):1871-82. doi: 10.1016/j.jmb.2014.02.018.

PMID:
24594356
7.

Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia.

Vesterager L, Christensen TØ, Olsen BB, Krarup G, Melau M, Forchhammer HB, Nordentoft M.

Schizophr Res. 2012 Nov;141(2-3):251-6. doi: 10.1016/j.schres.2012.08.023.

PMID:
23017825
8.
9.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators..

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933.

10.

Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage.

Olsen BB, Wang SY, Svenstrup TH, Chen BP, Guerra B.

BMC Mol Biol. 2012 Mar 9;13:7. doi: 10.1186/1471-2199-13-7.

11.

Characterization of ATM and DNA-PK wild-type and mutant cell lines upon DSB induction in the presence and absence of CK2 inhibitors.

Olsen BB, Fritz G, Issinger OG.

Int J Oncol. 2012 Feb;40(2):592-8. doi: 10.3892/ijo.2011.1227.

PMID:
21993375
12.

Role of polyamines in determining the cellular response to chemotherapeutic agents: modulation of protein kinase CK2 expression and activity.

Kreutzer JN, Olsen BB, Lech K, Issinger OG, Guerra B.

Mol Cell Biochem. 2011 Oct;356(1-2):149-58. doi: 10.1007/s11010-011-0949-4.

PMID:
21750985
13.

Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2α' levels.

Olsen BB, Fischer U, Rasmussen TL, Montenarh M, Meese E, Fritz G, Issinger OG.

Mol Cell Biochem. 2011 Oct;356(1-2):139-47. doi: 10.1007/s11010-011-0954-7.

PMID:
21750982
15.

Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface.

Raaf J, Bischoff N, Klopffleisch K, Brunstein E, Olsen BB, Vilk G, Litchfield DW, Issinger OG, Niefind K.

Biochemistry. 2011 Feb 1;50(4):512-22. doi: 10.1021/bi1013563.

PMID:
21142136
16.

Structural basis of the constitutive activity of protein kinase CK2.

Olsen BB, Guerra B, Niefind K, Issinger OG.

Methods Enzymol. 2010;484:515-29. doi: 10.1016/B978-0-12-381298-8.00025-3.

PMID:
21036248
17.

Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells.

Olsen BB, Issinger OG, Guerra B.

Oncogene. 2010 Nov 11;29(45):6016-26. doi: 10.1038/onc.2010.337.

PMID:
20711232
18.

Mapping of the interaction sites between Wee1 kinase and the regulatory beta-subunit of protein kinase CK2.

Olsen BB, Kreutzer JN, Watanabe N, Holm T, Guerra B.

Int J Oncol. 2010 May;36(5):1175-82.

PMID:
20372791
19.
20.

Resorufin: a lead for a new protein kinase CK2 inhibitor.

Sandholt IS, Olsen BB, Guerra B, Issinger OG.

Anticancer Drugs. 2009 Apr;20(4):238-48. doi: 10.1097/CAD.0b013e328326472e.

PMID:
19177021
Items per page

Supplemental Content

Loading ...
Support Center